Though teaching hospitals based in major metropolitan areas often deliver the most innovative care, malignant mesothelioma patients are frequently treated at community cancer clinics that are closest to their homes. The convenience of local treatment helps to preserve quality of life and can help cut costs. But Medicare’s Physician Fee Schedule (PFS) Final Rule for 2023 will mean that these patients, already facing health and economic challenges, will likely be paying higher out-of-pocket costs in the new year.
Community Cancer Clinics Offer Value to Mesothelioma Patients
It has long been known that mesothelioma patients can realize significant savings, as well as convenience, by accessing care at community cancer clinics that are close to their home and accessible to those who support and love them. Unfortunately, changes to Medicare’s reimbursement schedule will make this less likely in 2023, as physicians facing a 4.5 percent cut will be likely to succumb to buyouts from larger medical institutions.
Physicians who treat cancer patients in community settings, including those who care for those with rare cancers like malignant mesothelioma, are paid significantly less than those at larger hospitals, and have less opportunity for cost sharing. Facing additional cuts, these specialists are increasingly likely to succumb to financial pressures and consolidate with other physician practices. Unfortunately, the nonpartisan Medicare Payment Advisory Commission has reported that these arrangements lead to higher rates for patients “without meaningful changes in patient care.”
Groups Lobby Congress to Intervene in Cuts that Would Affect Mesothelioma Patients
Facing this significant financial impact, lobbyists on behalf of mesothelioma physicians and other independent physicians are encouraging Congress to take action against to stop these cuts. This action is represented by the Supporting Medicare Providers Act of 2022, which has been introduced by two members of the House of Representatives who are physicians, Ami Bera, M.D. (D-Calif.) and Larry Bucshon, M.D. (R-Ind.)
If passed, the bill would not only protect continuity of access to community cancer care, but would help patients diagnosed with malignant mesothelioma to keep their costs under control.
If you or someone you love has been diagnosed with malignant mesothelioma, the Patient Advocates at Mesothelioma.net can help you get the resources you need. Contact us today at 1-800-692-8608 for more information.
